University of California U. Vienna Charpentier Awarded Fourth U.S. CRISPRCas9 Patent

University of California, U. Vienna, Charpentier Awarded Fourth U.S. CRISPR-Cas9 Patent

A fourth U.S. patent covering CRISPR-Cas9 claims was granted today to the Regents of the University of California (UC), the University of Vienna, and CRISPR pioneer Emmanuelle Charpentier, PhD, director and scientific member at the Max Planck Institute of Infection Biology, Berlin. U.S. Patent No. 10,266,850, “Methods and compositions for RNA-directed target DNA modification and […]

More From BioPortfolio on "University of California, U. Vienna, Charpentier Awarded Fourth U.S. CRISPR-Cas9 Patent"